Last hope: experimental drug tested in single child with rare brain disease

This study gives one patient with Cree Leukoencephalopathy, a rare and fatal brain disease, access to an experimental drug called fosigotifator. The drug aims to slow or stop the brain damage that causes severe disability and early death. Researchers will track whether the patient survives or needs a breathing machine after two years.